Top Abstract Purchase Preview Related
Home
>
Node
>
Subnode

p53 gene mutations in non-small cell lung cancer from Thai patients

Petmitr, S.; Makthiengtrong, S.; Sutinont, P.; Migasena, P.

Journal of the Medical Association of Thailand 82(3): 250-255

1999

ISSN/ISBN: 0125-2208
PMID: 10410479
Document Number: 2074
Paraffin embedded tissues from twenty-two Thai patients with non-small cell lung cancer were studied for p53 gene mutations in exon 5 to 8 using polymerase chain reaction and single-stranded conformation polymorphism (PCR-SSCP) followed by thermal cycle sequencing. Results showed that point mutations in this region of p53 gene were present in 3 cases. One harboured the base change from GAC to AAC at codon 281, changing amino acid from aspartic acid to asparagine, whilst the other two cases were transversion of AAA (lysine) to ACA (threonine) at codon 292. All subjects with p53 mutation had a past history of tobacco smoking.

Document emailed within 1 workday
Secure & encrypted payments

p53 gene mutations in non-small cell lung cancer from Thai patients

Morodomi, Y.; Okamoto, T.; Kohno, M.; Katsura, M.; Takada, K.; Suzuki, Y.; Fujishita, T.; Kitahara, H.; Shimamatsu, S.; Yoshida, T.; Tagawa, T.; Okano, S.; Maehara, Y. 2015: Associations between driver gene mutations and cytotoxic chemosensitivity in patients with non-small cell lung cancer Anticancer Research 35(3): 1791-1796
Dahse, R.; Berndt, A.; Kosmehl, H. 2008: PCR-based testing for therapy-related EGFR mutations in patients with non-small cell lung cancer Anticancer Research 28(4b): 2265-2270
Mori, N.; Yokota, J.; Akiyama, T.; Sameshima, Y.; Okamoto, A.; Mizoguchi, H.; Toyoshima, K.; Sugimura, T.; Terada, M. 1990: Variable mutations of the RB gene in small-cell lung carcinoma Oncogene 5(11): 1713-1717
Sorraritchingchai, S.; Thongprasert, S.; Charoentum, C.; Chewasakulyong, B.; Moonprakan, S. 2004: Treatment of advanced non-small cell lung cancer with vinorelbine in elderly Thai patients Journal of the Medical Association of Thailand 87(4): 367-371
Riantawan, P.; Koanantakool, T.; Chotivatanapong, T.; Wongsangiem, M. 1999: Survival analysis of Thai patients with non-small-cell lung cancer undergoing surgical resection Journal of the Medical Association of Thailand 82(6): 552-557
Thongprasert, S.; Soorraritchingchai, S.; Chewaskulyong, B.; Charoentum, C.; Munprakan, S. 2006: A phase II study of docetaxel and carboplatin in Thai patients with advanced non-small-cell lung cancer Journal of the Medical Association of Thailand 89(2): 152-159
Thongprasert, S.; Intarapak, S.; Saengsawang, P.; Thaikla, K. 2005: Reliability of the Thai-modified Function Living Index Cancer questionnaire version 2 (T-FLIC 2) for the evaluation of quality of life in non-small cell lung cancer patients Journal of the Medical Association of Thailand 88(12): 1809-1815
Neill, H.B.; Miller, A.A.; Clamon, G.H.; Perry, M.C.; Crawford, J.; Green, M.R. 1997: A phase Ii study evaluating the efficacy of carboplatin, etoposide, and paclitaxel with granulocyte colony-stimulating factor in patients with stage IIIB and IV non-small cell lung cancer and extensive small cell lung cancer Seminars in Oncology 24(4 Suppl 12: S12
Mitsudomi, T.; Oyama, T.; Gazdar, A.F.; Minna, J.D.; Okabayashi, K.; Shirakusa, T. 1992: Mutations of ras and p53 genes in human non-small cell lung cancer cell lines and their clinical significance Nihon Geka Gakkai Zasshi 93(9): 944-947
Dong, Q.-g.; Han, B.-h.; Huang, J.-s.; Yang, L.-m.; Huang, J.; Zhao, C.-y.; Lu, L.-q. 2006: Analysis of EGFR mutations in 176 cases of non-small cell lung cancer Zhonghua Zhong Liu Za Zhi 28(9): 686-690
Mańdziuk, S.ła.; Dudzisz-Sledź, M.; Korszeń-Pilecka, I.; Milanowski, J.; Wojcierowski, J.; Korobowicz, E. 2003: Expression of p53 gene in stage IIIA non-small cell lung cancer in patients after neoadjuvant chemotherapy with Vepesid and Cisplatin Annales Universitatis Mariae Curie-Sklodowska. Sectio D: Medicina 58(1): 154-157
Kovalchuk, O.; Chyczewska, E.; Niklinska, W.; Niklinski, J.; Naumnik, W.; Chyczewski, L. 2001: K-ras codon 12 mutations detected with enriched PCR method in operable non-small cell lung cancer Folia Histochemica et Cytobiologica 39(Suppl 2): 68-69
Shepherd, F.A. 2016: Should EGFR tyrosine kinase inhibitors be used in non-small cell lung cancer in the absence of EGFR mutations? Yes, there is a role for EGFR TKIs in these patients Clinical Advances in Hematology and Oncology: H&o 14(1): 41-43
Li, Z.; Zhang, L-jun.; Wang, W-ping.; Guo, K.; Shao, J-yong.; Rong, T-hua. 2011: Correlation between EGFR gene mutation and high copy number and their association with the clinicopathological features in Chinese patients with non-small cell lung cancer Zhonghua Zhong Liu Za Zhi 33(9): 666-670
Jantip, J.; Tanthanuch, M.; Kanngurn, S.; Karnchanawanichkul, W.; Pripatnanont, C.; Sangkhathat, S.; Thongsuksai, P. 2013: Mutations of fibroblast growth factor receptor 3 gene (FGFR3) in transitional cell carcinoma of urinary bladder in Thai patients [Revision-2a Journal of the Medical Association of Thailand 96(8): 976-983
Shi, Y. 2015: The Guideline for Diagnosis and Treatment of Chinese Patients with sensitizing EGFR Mutation or ALK Fusion Gene-Positive Non-Small Cell Lung Cancer (2015 Version) Zhonghua Zhong Liu Za Zhi 37(10): 796-799
Saxena, A.; Nagasaka, M.; Li, Z.; Becker, D.J.; Levy, B.P. 2014: Double trouble: a case of concurrent de novo T790M and L858R EGFR mutations in treatment-naive advanced non-small-cell lung cancer Oncology 28(6): 526; 528 530, 534
Dou, Y.-l.; Qi, X.-l.; Xin, L.; Chen, D.; Zhang, H.-q.; Cui, Q.-c. 2013: Value of detecting epidermal growth factor receptor mutations in non-small cell lung cancer tissue by TaqMan-amplification refractory mutation system Zhonghua Yi Xue Za Zhi 93(10): 768-771
Ouyang, Q-chang.; Hu, C-ping.; Shi, L-jie. 2003: Non small cell lung cancer gene expression profiles by cDNA microarrays Hunan Yi Ke Da Xue Xue Bao 28(1): 9-12
Gresner, P.; Gromadzinska, J.; Wasowicz, W. 2009: Reference genes for gene expression studies on non-small cell lung cancer Acta Biochimica Polonica 56(2): 307-316